retatrutide classification Triple Agonist (GLP-1/GIP/GCG) Switching from tirzepatide to retatrutide:

Dose at 300mcg tesamorelin / 100mcg ipamorelin per injection (10 units on your insulin syringe)

(31) The time at which someone starts a treatment for obesity can itself be correlated with mental health difficulties, and the effects of the medication on weight, whether this is a dramatic reduction in weight, or a disappointing lack of weight reduction, can also trigger changes in mental health. (32) Based on major long-term trials, including FLOW (chronic kidney disease), SELECT (obesity/cardiovascular disease without diabetes), and SUSTAIN-6 (type 2 diabetes), semaglutide has demonstrated significant benefits across the cardiovascular and renal systems

Jordan E

Read advice on safety for you and your baby before starting treatment